Get started
Orpea ACTOrpea ACTOrpea ACT

Orpea ACT

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.83 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.14 USD
Net income (FY)
‪−426.58 M‬ USD
Revenue (FY)
‪5.83 B‬ USD
Shares float
‪79.13 M‬
Beta (1Y)
0.96

Employees


Employees (FY)
‪83.49 K‬
Change (1Y)
‪+5.02 K‬ +6.39%
Revenue / Employee (1Y)
‪69.88 K‬ USD
Net income / Employee (1Y)
‪−5.11 K‬ USD

About Emeis


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Laurent Guillot
Website
emeis-group.com
Headquarters
Puteaux
Founded
1995
IPO date
Apr 16, 2002
Identifiers
2
ISIN FR001400NLM4
Emeis SA engages in the operation of geriatric healthcare facilities. It operates through the following geographical segments: France Benelux UK Ireland, Central Europe, Eastern Europe, Iberian Peninsula/Latin America, and Others. Its services include nursing homes, psychiatric care clinics, home care, and post-acute and rehabilitation clinics. The company was founded by Jean-Claude Marian in 1989 and is headquartered in Puteaux, France.

Check out other big names from the same industry as ORPEF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


FR0011365634
Emeis SA 5.25% 04-DEC-2026
Yield to maturity
5.24%
Maturity date
Dec 4, 2026
FR0014014Y63
Emeis SA FRN 31-DEC-2031
Yield to maturity
—
Maturity date
Dec 31, 2031

See all ORPEF bonds 

ETFs holding the stock


AVDV
Avantis International Small Cap Value ETF
Weight
0.14%
Market value
‪25.86 M‬
USD
FNDF
Schwab Fundamental International Equity ETF
Weight
0.03%
Market value
‪6.31 M‬
USD
VSS
Vanguard FTSE All-Wld ex-US SmCp Idx ETF
Weight
0.04%
Market value
‪4.91 M‬
USD
SCZ
iShares MSCI EAFE Small-Cap ETF
Weight
0.03%
Market value
‪4.90 M‬
USD
VGK
Vanguard FTSEEuropean ETF
Weight
0.01%
Market value
‪3.32 M‬
USD
XXSC
Xtrackers MSCI Europe Small Cap UCITS ETF Capitalisation 1C
Weight
0.08%
Market value
‪3.09 M‬
USD
SCHC
Schwab International Small-Cap Equity ETF
Weight
0.05%
Market value
‪2.95 M‬
USD
CSEMUS.EUR
iShares MSCI EMU Small Cap UCITS ETF
Weight
0.19%
Market value
‪2.51 M‬
USD
ZPRX
SPDR MSCI Europe Small Cap Value Weighted UCITS ETF
Weight
0.37%
Market value
‪2.43 M‬
USD
AVDE
Avantis International Equity ETF
Weight
0.02%
Market value
‪2.34 M‬
USD
EMUSC.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR acc- Capitalisation
Weight
0.20%
Market value
‪1.68 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of ORPEF is 6.60 USD — it has decreased by −53.59% in the past 24 hours. Watch Orpea ACT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Orpea ACT stocks are traded under the ticker ORPEF.
We've gathered analysts' opinions on Orpea ACT future price: according to them, ORPEF price has a max estimate of 20.63 USD and a min estimate of 9.31 USD. Watch ORPEF chart and read a more detailed Orpea ACT stock forecast: see what analysts think of Orpea ACT and suggest that you do with its stocks.
ORPEF reached its all-time high on Jan 28, 2021 with the price of 141,765.70 USD, and its all-time low was 0.001 USD and was reached on Dec 29, 2023. View more price dynamics on ORPEF chart.
See other stocks reaching their highest and lowest prices.
ORPEF stock is 115.45% volatile and has beta coefficient of 0.96. Track Orpea ACT stock price on the chart and check out the list of the most volatile stocks — is Orpea ACT there?
Today Orpea ACT has the market capitalization of ‪2.83 B‬, it has increased by 23.33% over the last week.
Yes, you can track Orpea ACT financials in yearly and quarterly reports right on TradingView.
Orpea ACT is going to release the next earnings report on May 8, 2026. Keep track of upcoming events with our Earnings Calendar.
ORPEF net income for the last half-year is ‪−161.94 M‬ USD, while the previous report showed ‪−160.46 M‬ USD of net income which accounts for −0.92% change. Track more Orpea ACT financial stats to get the full picture.
As of Feb 14, 2026, the company has ‪83.49 K‬ employees. See our rating of the largest employees — is Orpea ACT on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Orpea ACT EBITDA is ‪919.46 M‬ USD, and current EBITDA margin is 12.37%. See more stats in Orpea ACT financial statements.
Like other stocks, ORPEF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Orpea ACT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Orpea ACT technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Orpea ACT stock shows the sell signal. See more of Orpea ACT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.